Editorial commentary: Arson in the artery: Who set the atheroma aflame?
References (24)
- et al.
Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week
J Am Coll Cardiol
(2018) Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond
J Am Coll Cardiol
(2017)- et al.
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
Lancet
(2008) - et al.
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: rationale and design of the INVESTED trial
Am Heart J
(2018) - et al.
Triglycerides and cardiovascular disease
The Lancet
(2014) - et al.
Rationale and design of the pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes (PROMINENT) study
Am Heart J
(2018) - et al.
Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae
J Nutr
(1992) - et al.
The pathogenesis of atherosclerosis (second of two parts)
N Engl J Med
(1976) - et al.
The pathogenesis of atherosclerosis (first of two parts)
N Engl J Med
(1976) - et al.
Antiinflammatory therapy with canakinumab for atherosclerotic disease
N Engl J Med
(2017)
Inflammation, infection and atherosclerosis
Trends Cardiovasc Med
(2019)
Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation
Circulation
(2013)
Cited by (0)
© 2019 Elsevier Inc. All rights reserved.